serotonin syndrome due to combined toxicity of moclobemide and paroxetine
AI-generated summary
A 47-year-old woman with a long history of prescription drug abuse died from serotonin syndrome caused by combined toxicity of moclobemide (MAOI) and paroxetine (SSRI). She had experienced multiple previous overdoses and suffered brain damage from a 1992 insulin overdose. Key failures included: a locum doctor's misdiagnosis of UTI when she presented with fever, sweating, and abdominal pain (actually serotonin syndrome); a GP switching her from one SSRI to MAOI without adequate washout warning or consultation with the previous prescriber; and crucially, a pharmacist dispensing both incompatible medications together on the day before death. Although the pharmacist warned the patient, she should have contacted the prescribing doctor rather than relying on her assessment of the patient's mental state. Multiple clinicians failed to recognize the cognitive deficits and medication non-compliance patterns documented by psychiatry in 1993. Earlier hospital admission when symptoms emerged might have allowed ICU temperature management.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
Specialties
general practicepsychiatryemergency medicinepharmacyforensic medicinepharmacology
serotonin syndromedepressionanxietypresumed urinary tract infectionbrain damage from previous insulin overdosehyperpyrexiaprescription drug abusecognitive impairmentmedication non-compliance
Contributing factors
patient took both MAOI and SSRI in overdose despite warnings
inadequate washout period between switching antidepressants
pharmacist dispensed both incompatible drugs together
GP switched antidepressant without consulting previous prescriber and without adequate warning
locum doctor's misdiagnosis of UTI when patient presented with serotonin syndrome symptoms
patient's history of cognitive impairment and medication non-compliance not communicated between doctors
patient not admitted to hospital despite fever and distress
doctor-shopper pattern not effectively managed across multiple practitioners
Coroner's recommendations
Pharmacy systems should flag when prescriptions for dangerous drug combinations are presented together, particularly when written by different prescribers
Pharmacists should contact prescribing doctors when potentially dangerous drug interactions are identified, rather than relying on assessment of patient mental state
Doctors switching antidepressant medications should consult with the previous prescriber about the reasons for the original choice
General practitioners should maintain awareness of and communicate patients' history of medication non-compliance and previous overdoses
When patients present with fever, sweating, agitation, and muscle symptoms, serotonin syndrome should be considered in differential diagnosis for those on serotonergic medications
Patients presenting with acute systemic symptoms should be encouraged to seek hospital admission rather than home management
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.